Ken Griffin’s Virtus Biotech ETF BBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-14,953
| Closed | -$1.05M | – | 12664 |
|
|
2025
Q3 | $1.05M | Buy |
14,953
+7,834
| +110% | +$513K | ﹤0.01% | 7444 |
|
|
2025
Q2 | $415K | Sell |
7,119
-5,086
| -42% | -$287K | ﹤0.01% | 9073 |
|
|
2025
Q1 | $715K | Buy |
+12,205
| New | +$749K | ﹤0.01% | 7699 |
|
|
2024
Q3 | – | Sell |
-4,638
| Closed | -$273K | – | 14238 |
|
|
2024
Q2 | $273K | Buy |
4,638
+732
| +19% | +$40.8K | ﹤0.01% | 9327 |
|
|
2024
Q1 | $221K | Buy |
+3,906
| New | +$228K | ﹤0.01% | 10116 |
|
|
2023
Q2 | – | Sell |
-36,512
| Closed | -$1.8M | – | 14340 |
|
|
2023
Q1 | $1.8M | Buy |
36,512
+28,919
| +381% | +$1.45M | ﹤0.01% | 5591 |
|
|
2022
Q4 | $374K | Sell |
7,593
-584
| -7% | -$27.9K | ﹤0.01% | 8853 |
|
|
2022
Q3 | $371K | Sell |
8,177
-950
| -10% | -$43.9K | ﹤0.01% | 9105 |
|
|
2022
Q2 | $376K | Buy |
9,127
+316
| +4% | +$12.6K | ﹤0.01% | 9279 |
|
|
2022
Q1 | $383K | Buy |
+8,811
| New | +$379K | ﹤0.01% | 10019 |
|
|
2021
Q3 | – | Sell |
-21,306
| Closed | -$1.14M | – | 13791 |
|
|
2021
Q2 | $1.14M | Buy |
21,306
+84
| +0.4% | +$4.43K | ﹤0.01% | 8028 |
|
|
2021
Q1 | $1.11M | Sell |
21,222
-82
| -0.4% | -$4.57K | ﹤0.01% | 7853 |
|
|
2020
Q4 | $1.13M | Buy |
21,304
+13,481
| +172% | +$691K | ﹤0.01% | 6538 |
|
|
2020
Q3 | $373K | Buy |
7,823
+90
| +1% | +$4.19K | ﹤0.01% | 7771 |
|
|
2020
Q2 | $367K | Sell |
7,733
-1,703
| -18% | -$76.1K | ﹤0.01% | 7589 |
|
|
2020
Q1 | $353K | Sell |
9,436
-3,000
| -24% | -$124K | ﹤0.01% | 7042 |
|
|
2019
Q4 | $541K | Sell |
12,436
-18
| -0.1% | -$723 | ﹤0.01% | 6691 |
|
|
2019
Q3 | $447K | Buy |
12,454
+1,660
| +15% | +$63.6K | ﹤0.01% | 6938 |
|
|
2019
Q2 | $443K | Buy |
10,794
+5,184
| +92% | +$213K | ﹤0.01% | 7002 |
|
|
2019
Q1 | $251K | Sell |
5,610
-5,396
| -49% | -$226K | ﹤0.01% | 7871 |
|
|
2018
Q4 | $384K | Buy |
11,006
+1,956
| +22% | +$74.4K | ﹤0.01% | 6850 |
|
|
2018
Q3 | $410K | Sell |
9,050
-1,497
| -14% | -$66.9K | ﹤0.01% | 7021 |
|
|
2018
Q2 | $463K | Buy |
+10,547
| New | +$447K | ﹤0.01% | 6496 |
|
|
2017
Q2 | – | Sell |
-12,453
| Closed | -$470K | – | 7465 |
|
|
2017
Q1 | $470K | Buy |
+12,453
| New | +$456K | ﹤0.01% | 5134 |
|
|
2016
Q2 | – | Sell |
-8,756
| Closed | -$216K | – | 6814 |
|
|
2016
Q1 | $216K | Sell |
8,756
-1,787
| -17% | -$43.5K | ﹤0.01% | 5543 |
|
|
2015
Q4 | $325K | Sell |
10,543
-774
| -7% | -$23.5K | ﹤0.01% | 5099 |
|
|
2015
Q3 | $312K | Buy |
+11,317
| New | +$382K | ﹤0.01% | 5501 |
|
Other funds holding BBP
PCIA
CAMG
ARC
IFG
CFP
Ken Griffin's BBP Position: Q4 2025 in Review
Ken Griffin sold out of Virtus Biotech ETF (BBP) in Q4 2025, closing a stake of 14,953 shares — an estimated $1.05M sold.
Ken Griffin first reported a position in BBP in Q3 2015 and held it in 27 quarters. The position peaked at $1.8M in Q1 2023. 20 funds tracked by Wall St. Rank hold BBP as of Q4 2025.
- Ken Griffin reported no remaining Virtus Biotech ETF position as of Q4 2025 after selling out during the quarter.
- Ken Griffin sold 14,953 Virtus Biotech ETF shares in Q4 2025, an estimated $1.05M.
- Ken Griffin first reported a position in Virtus Biotech ETF in Q3 2015 and held it in 27 quarters.
- Ken Griffin's Virtus Biotech ETF position peaked at $1.8M in Q1 2023.
- 20 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2025.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.